Clinical Trial Update: Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 extension study update for armodafinil as adjunctive therapy in adults with major depression associated with Bipolar I Disorder; study terminated with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Depression | Phase 3 | Status: TERMINATED | Results posted: 2015-01-26